US BASED PHARMAZZ
Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in IndiaDr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The pa...22 Mar, 2024, 05.21 PM IST
Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...16 Feb, 2024, 12.54 AM IST
Sun Pharma unit inks licensing pact with US-based firm to introduce drug to treat stroke"The Phase 3 clinical trial for Tyvalzi conducted in India demonstrated statistically and clinically meaningful improvement in neurological...14 Sep, 2023, 12.26 PM IST
Load More